Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Pannecouque

Showing results (151-160 of 427) with videos related to

Pageof 43
Sort By:
European Journal of Medicinal Chemistry|June 9, 2016
Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocketWenmin Chen, Peng Zhan, Dirk Daelemans, et al.
Bioorganic & Medicinal Chemistry|March 17, 2004
Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of FoscarnetValérie Gagnard, Alain Leydet, Alain Morère, et al.
Current Biology : CB|August 15, 2002
New class of HIV integrase inhibitors that block viral replication in cell cultureChristophe Pannecouque, Wim Pluymers, Bénédicte Van Maele, et al.
Bioorganic & Medicinal Chemistry|March 5, 2008
Synthesis and anti-HIV1 biological activity of novel 5''-ATSAO compoundsCyrille Tomassi, Albert Nguyen Van Nhien, José Marco-Contelles, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2018
Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agentsKonstantina Karypidou, Sergio R Ribone, Mario A Quevedo, et al.
Bioorganic Chemistry|April 9, 2024
Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubilityJin-Si Wang, Ke-Xin Zhao, Kun Zhang, et al.
European Journal of Medicinal Chemistry|December 28, 2022
Development of novel S-N<sub>3</sub>-DABO derivatives as potent non-nucleoside reverse transcriptase inhibitors with improved potency and selectivityXu Ling, Qing-Qing Hao, Wen-Juan Huang, et al.
Antiviral Chemistry & Chemotherapy|January 15, 2011
Synthesis and an antiviral activity evaluation of nucleoside 5´-O-(N-acyl) phosphoramidatesKatarzyna Kulik, Ewa Radzikowska, Renata Kaczmarek, et al.
Journal of Medicinal Chemistry|November 28, 2015
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV ActivityLuca Sancineto, Alice Mariotti, Luana Bagnoli, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 19, 2002
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivativesAngela Rao, Anna Carbone, Alba Chimirri, et al.
Pageof 43

Showing results (151-160 of 427) with videos related to

Sort By:
Pageof 43
European Journal of Medicinal Chemistry|June 9, 2016
Structural optimization of pyridine-type DAPY derivatives to exploit the tolerant regions of the NNRTI binding pocketWenmin Chen, Peng Zhan, Dirk Daelemans, et al.
Bioorganic & Medicinal Chemistry|March 17, 2004
Synthesis and in vitro evaluation of S-acyl-3-thiopropyl prodrugs of FoscarnetValérie Gagnard, Alain Leydet, Alain Morère, et al.
Current Biology : CB|August 15, 2002
New class of HIV integrase inhibitors that block viral replication in cell cultureChristophe Pannecouque, Wim Pluymers, Bénédicte Van Maele, et al.
Bioorganic & Medicinal Chemistry|March 5, 2008
Synthesis and anti-HIV1 biological activity of novel 5''-ATSAO compoundsCyrille Tomassi, Albert Nguyen Van Nhien, José Marco-Contelles, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2018
Synthesis, biological evaluation and molecular modeling of a novel series of fused 1,2,3-triazoles as potential anti-coronavirus agentsKonstantina Karypidou, Sergio R Ribone, Mario A Quevedo, et al.
Bioorganic Chemistry|April 9, 2024
Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubilityJin-Si Wang, Ke-Xin Zhao, Kun Zhang, et al.
European Journal of Medicinal Chemistry|December 28, 2022
Development of novel S-N<sub>3</sub>-DABO derivatives as potent non-nucleoside reverse transcriptase inhibitors with improved potency and selectivityXu Ling, Qing-Qing Hao, Wen-Juan Huang, et al.
Antiviral Chemistry & Chemotherapy|January 15, 2011
Synthesis and an antiviral activity evaluation of nucleoside 5´-O-(N-acyl) phosphoramidatesKatarzyna Kulik, Ewa Radzikowska, Renata Kaczmarek, et al.
Journal of Medicinal Chemistry|November 28, 2015
Design and Synthesis of DiselenoBisBenzamides (DISeBAs) as Nucleocapsid Protein 7 (NCp7) Inhibitors with anti-HIV ActivityLuca Sancineto, Alice Mariotti, Luana Bagnoli, et al.
Farmaco (Societa Chimica Italiana : 1989)|October 19, 2002
Synthesis and anti-HIV activity of 2,3-diaryl-1,3-thiazolidin-4-(thi)one derivativesAngela Rao, Anna Carbone, Alba Chimirri, et al.
Pageof 43